Progressive dyspnoea, pleural effusions and lytic bone lesions.

2005;26:630–6. 42. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001;285:2486–97. 43. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61:772–8. 44. Martinez FJ, Foster G, Curtis JL, et al, for the NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006;173:1326–34. 45. Troosters T, Casaburi R, Gosselink R, et al. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:19–38. 46. World Health Organization. The world health report 2002: reducing risk, promoting healthy life. Geneva: World Health Organization, 2002. 47. Wang TJ, Evans JC, Benjamin EJ, et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108:977–82. 48. European Society of Cardiology (Working Group Report). Recommendations for exercise training in chronic heart failure patients. Eur Heart J 2001;22:125–35. 49. Lenzen M, Scholte op Reimer W, Norekval TM, et al. Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization. Eur J Cardiovasc Nurs 2006;5:115–21. 50. Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004;351:2870–4.